Kucharczyk, T.; Krawczyk, P.; Kowalski, D.M.; Płużański, A.; Kubiatowski, T.; Kalinka, E.
RET Proto-Oncogene—Not Such an Obvious Starting Point in Cancer Therapy. Cancers 2022, 14, 5298.
https://doi.org/10.3390/cancers14215298
AMA Style
Kucharczyk T, Krawczyk P, Kowalski DM, Płużański A, Kubiatowski T, Kalinka E.
RET Proto-Oncogene—Not Such an Obvious Starting Point in Cancer Therapy. Cancers. 2022; 14(21):5298.
https://doi.org/10.3390/cancers14215298
Chicago/Turabian Style
Kucharczyk, Tomasz, Paweł Krawczyk, Dariusz M. Kowalski, Adam Płużański, Tomasz Kubiatowski, and Ewa Kalinka.
2022. "RET Proto-Oncogene—Not Such an Obvious Starting Point in Cancer Therapy" Cancers 14, no. 21: 5298.
https://doi.org/10.3390/cancers14215298
APA Style
Kucharczyk, T., Krawczyk, P., Kowalski, D. M., Płużański, A., Kubiatowski, T., & Kalinka, E.
(2022). RET Proto-Oncogene—Not Such an Obvious Starting Point in Cancer Therapy. Cancers, 14(21), 5298.
https://doi.org/10.3390/cancers14215298